CFDA: Draft guidance? [RSABE / ABEL]

posted by libaiyi – China, 2018-06-13 03:39 (1061 d 06:16 ago) – Posting: # 18895
Views: 4,504

Thanks for you reply.

Another question,
how to write the null hypothesis and alternative hypothesis for BE based on FDA or EMA method?

Complete thread:

 Admin contact
21,445 posts in 4,482 threads, 1,510 registered users;
online 13 (0 registered, 13 guests [including 5 identified bots]).
Forum time: Sunday 09:55 CEST (Europe/Vienna)

It is better to know some of the questions
than all of the answers.    James Thurber

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz